Fusion driven JMML: a novel CCDC88C-FLT3 fusion responsive to sorafenib identified by RNA sequencing.
Leukemia
; 34(2): 662-666, 2020 02.
Article
in En
| MEDLINE
| ID: mdl-31511612
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Intracellular Signaling Peptides and Proteins
/
Fms-Like Tyrosine Kinase 3
/
Leukemia, Myelomonocytic, Juvenile
/
Sorafenib
/
Microfilament Proteins
/
Antineoplastic Agents
Type of study:
Prognostic_studies
Limits:
Animals
/
Humans
/
Infant
/
Male
Language:
En
Journal:
Leukemia
Journal subject:
HEMATOLOGIA
/
NEOPLASIAS
Year:
2020
Document type:
Article
Affiliation country:
United States